Boehringer Ingelheim Vetmedica GmbH, Ingelheim am Rhein, Germany.
Department of Poultry Science, University of Arkansas, Fayetteville, AR, USA.
Parasitol Res. 2019 Jul;118(7):2009-2026. doi: 10.1007/s00436-019-06343-5. Epub 2019 May 31.
Coccidiosis is a parasitic disease of a wide variety of animals caused by coccidian protozoa. The coccidia are responsible for major economic losses of the livestock industry. For example, the annual cost due to coccidiosis to the global poultry industry has been estimated to exceed US$ 3 billion annually. Currently available drugs for the control of this disease are either polyether ionophorous antibiotics that are derived from fermentation products, or synthetic compounds, produced by chemical synthesis. Unfortunately, no new drugs in either category have been approved for use for decades. Resistance has been documented for all those of the drugs currently employed and therefore the discovery of novel drugs with unique modes of action is imperative if chemotherapy is to remain the principal means to control this disease. This chapter aims to give an overview of the efficacy and mode of action of the current compounds used to control coccidiosis in livestock and provides a brief outlook of research needs for the future.
球虫病是一种由球虫原生动物引起的多种动物的寄生虫病。球虫可导致畜牧业的重大经济损失。例如,据估计,全球家禽业因球虫病造成的年成本每年超过 30 亿美元。目前用于控制这种疾病的药物要么是源自发酵产物的聚醚离子载体抗生素,要么是通过化学合成生产的合成化合物。不幸的是,几十年来,这两类药物都没有新的药物获得批准使用。所有现有的药物都已经出现了耐药性,因此,如果化疗仍然是控制这种疾病的主要手段,那么发现具有独特作用模式的新型药物是至关重要的。本章旨在概述目前用于控制家畜球虫病的化合物的功效和作用模式,并简要展望未来的研究需求。